ADVERTISEMENT
  • Hausa Edition
  • Podcast
  • Conferences
  • LeVogue Magazine
  • Business News
  • Print Advert Rates
  • Online Advert Rates
  • Contact Us
Saturday, September 20, 2025
Leadership Newspapers
Read in Hausa
  • Home
  • News
  • Politics
  • Business
  • Sport
    • Football
  • Health
  • Entertainment
  • Education
  • Opinion
    • Editorial
    • Columns
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
    • Football
  • Health
  • Entertainment
  • Education
  • Opinion
    • Editorial
    • Columns
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
Leadership Newspapers
No Result
View All Result

Tweaked Vaccine Safe Against Omicron – Pfizer

by Agency Report
3 years ago
in News
Pfizer
Share on WhatsAppShare on FacebookShare on XTelegram

Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer Americans updated booster shots this fall.

Advertisement

The vaccines currently used in the U.S. still offer strong protection against severe COVID-19-19 disease and death — especially if people have gotten a booster dose. But those vaccines target the original coronavirus strain and their effectiveness against any infection dropped markedly when the super-contagious omicron mutant emerged.

Now with omicron’s even more transmissible relatives spreading widely, the Food and Drug Administration is considering ordering a recipe change for the vaccines made by both Pfizer and rival Moderna in hopes that modified boosters could better protect against another COVID-19 surge expected this fall and winter.

Pfizer and its partner BioNTech studied two different ways of updating their shots — targeting just omicron, or a combination booster that adds omicron protection to the original vaccine. They also tested whether to keep today’s standard dosage — 30 micrograms — or to double the shots’ strength.

In a study of more than 1,200 middle-aged and older adults who’d already had three vaccine doses, Pfizer said both booster approaches spurred a substantial jump in omicron-fighting antibodies.

Related News

All On Invests $1.5m To Advance E-waste Recycling In Nigeria

3 minutes ago

AMCE Spearheads Oncology Breakthroughs, Seeks United Front At ARCON

10 minutes ago

“Based on these data, we believe we have two very strong omicron-adapted candidates,” Pfizer CEO Albert Bourla said in a statement.

Join Our WhatsApp Channel

Tags: Pfizer
SendShare10171Tweet6357Share

Other News Updates

Business

All On Invests $1.5m To Advance E-waste Recycling In Nigeria

2025/09/20
News

AMCE Spearheads Oncology Breakthroughs, Seeks United Front At ARCON

2025/09/20
News

Sunshine Queens, Castmog Ladies, Two Others Gain Promotion To NWFL

2025/09/20
Business

Foreign, Domestic Investors’ NGX Trade Declines To N908bn In August

2025/09/20
News

PTML Customs Urges Importers, Agents On Compliance In Cargo Declarations

2025/09/20
Business

Right Violations: NCAA Threatens Sanction On Qatar Airways, Others

2025/09/20
Leadership Conference advertisement

LATEST

All On Invests $1.5m To Advance E-waste Recycling In Nigeria

AMCE Spearheads Oncology Breakthroughs, Seeks United Front At ARCON

Boxing: Joshua Set To Fight In Nigeria In 2026

World Athletics Championships: Ezekiel Nathaniel Sets New Nigerian 400mH Record

World Athletics Championships: Amusan Dedicates Silver Medal To Fans

D’Tigers Drops In Latest FIBA World Ranking

EPL: Amorim Could Be Sacked By Man Utd After Chelsea Game – Shearer

Ofem, Akintokun Secure Positions On Nigeria Cricket Federation Board

NCF Elections: Emeka Onyeama Unveils 7-Point Agenda To Grow Cricket In Nigeria

Life Harder For My Dad Than Footballers – Maresca

© 2025 Leadership Media Group - All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
    • Football
  • Health
  • Entertainment
  • Education
  • Opinion
    • Editorial
    • Columns
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us

© 2025 Leadership Media Group - All Rights Reserved.